DNA Probe-based Diagnostic Market

 

DNA Probe-Based Diagnostic Market to be Worth US$ 21.5 Billion by 2030

 

Reports and Insights (R&I) has published a new report titled, “DNA Probe-based Diagnostics Market: Opportunity Analysis and Future Assessment 2022-2030

Global DNA probe-based diagnostic market, By Product (DNA Probes-Based, Products Direct Detection of Target Sequence, Nucleic Acid Amplification, Gene Detection Using DNA Chips, Gene Detection by DNA Sequencing), By End-User (Infectious disease testing, Cancer testing), and By Region (North America, Europe, Asia Pacific, Latin America, Middle East, & Africa) is expected to grow at a significant CAGR for the period between 2022 and 2030.

The global DNA probe-based diagnostics market is estimated to reach at a value of US$ 15.3 Bn by the end of 2022 and expected to reach at a value of US$ 21.5 Bn by 2030 with a significant CAGR of 4.4%

As per the report, the rising public awareness of these DNA probe-based diagnostic techniques across the world is majorly driving the growth of the global DNA probe-based diagnostic market.

The disease or hereditary trait can occur due to the irregularity of genes, a human genome is accounted to contain 100,000 approximately. A single standard stranded sequence of DNA/RNA is known as a probe, which is mainly used to search for its complementary sequence in the sample genome. Chemical structure of DNA is mainly associated with the DNA probes-based technology by eliminating the presence of anomalous gene sequences on the DNA strand.

Moreover, technology like DNA probe-based are considerably applied in diagnostics and presently its getting popularity in various other fields such as molecular biology, biological sample preparation, data handling etc. Owing to which, the global DNA probe-based diagnostic market is projected to witness significant growth in the near future.

The DNA probe-based technology profoundly promotes its utility in prenatal diagnosis and carrier detection, hence the DNA probe-based diagnostic market is expected to grow positively during the forthcoming future.

Additionally, in the past few years, the DNA probe-based technology is rising its prominence in diagnosing infectious diseases including vaginitis, which is also acting as a major driver and propelling the growth of the global DNA probe-based diagnostics market.

Moreover, over the past decade, the investments in pharmaceuticals and pharmacogenomics research and development have increased substantially, which correspondingly also opened the way for further advancements in DNA array technologies, leading to the initiation of advanced equipment assisting the progress of execution of tests with accuracy, higher speed, and reliability and is, therefore, influencing the growth of the global DNA probe-based diagnostic market undeniably.

Another major factor acting as a positive aspect in augmenting the growth of the global DNA probe-based diagnostic market is the advent of novel methods for high-volume testing.

Furthermore, some other factors like growth in geriatric population and rising disposable income among the population across the globe are also fueling the DNA probe-based diagnostic market.

However, factors like recombination between the marker and disease alleles, genetic heterogeneity, and incorrect pedigree data or non-paternity leading to erroneous diagnosis are likely to restrain the growth of the global DNA probe-based diagnostic market.

R&I Study identifies some of the key participating players in the global DNA probe-based diagnostic market globally are Abbott Laboratories, F. Hoffmann La Roche, GE Healthcare, Thermo Fisher Scientific, BD, Biogenex, bioMerieux, Biolegio, Luminex, and MP Biomedicals, among others.

About Reports and Insights:

Reports and Insights (R&I) is committed to provide deep insights that serve as a creative tool for the client that enables it to perform confidently in the market. At R&I we adhere to the client's needs and regularly ponder to bring out more valuable and real outcomes for our customers. We are equipped with a strategically enhanced group of researchers and analysts that redefines and stabilizes the business polarity in different categorical dimensions of the market.

Contact Us:

Reports and Insights (R&I)

Tel: +1-(718)-312-8686

For Sales Query: [email protected]

For New Topics & Other Info: [email protected]





This site uses cookies, including third-party cookies, that help us to provide and improve our services. Privacy Policy

OK